Evidence map›Paper›PMID 22007787›Full record

ReviewChemical reviews2012

Biocompatible and bioactive surface modifications for prolonged in vivo efficacy.

Steven R Meyers, Mark W Grinstaff

Abstract readReview
In one paragraph

Review in Chemical reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Mechanical Properties of a Solvated Biomolecule: RGD (1FUV) Peptide.International journal of molecular sciences · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Steven R MeyersDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, USA.
Mark W Grinstaff

Funding

Bacteriophobic Coatings for Inhibition of Pathogenic BiofilmsR01AR054872 · NIAMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GRINSTAFF, MARK W. · 2008 to 2011
$2.1M
Interfacial BiomaterialsR01EB000501 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GRINSTAFF, MARK W · 2003 to 2006
$1.3M
NIAMS NIH HHS AR-054872NIAMS NIH HHS R01 AR054872NIBIB NIH HHS EB-000501NIBIB NIH HHS R01 EB000501
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amino Acid SequenceAnimalsBiofoulingBiomimeticsCoated Materials, BiocompatibleHumansMolecular Sequence DataProstheses and ImplantsSurface PropertiesTime FactorsCoated Materials, Biocompatible

Identifiers

PMID22007787
PMCPMC3878818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.